Dr. Grossman leads a multidisciplinary team of experts at the Hoag Family Cancer Institute dedicated to advancing cancer care through transformative research and patient-centered care. He not only spearheads cancer research but also ensures transparency in its progress, empowering patients and their families with knowledge and hope. His leadership continues to shape the institute as a premier destination for world-class cancer care.
Dr. Grossman is an internationally recognized clinician and researcher with deep expertise in gastrointestinal cancers, including pancreatic, colorectal, and esophageal cancers. He has a strong track record of driving discovery and innovation, particularly in pancreatic cancer, which is one of the most complex and challenging cancers to treat. With his extensive background in translational research, he ensures Hoag patients have access to the latest cancer advancements in a compassionate, patient-centered environment.
Dr. Grossman believes that Hoag’s unique ability to blend pioneering science with compassionate, personalized care is what sets Hoag apart, not just regionally, but nationally.
Colorectal cancer is a type of cancer that starts in the colon or rectum, which are parts of the large intestine. Early detection is crucial for effective treatment.
Esophageal cancer is a malignancy in the esophagus, often linked to smoking, alcohol use, and acid reflux. It can cause difficulty swallowing, chest pain, and weight loss.
Pancreatic cancer is where malignant cells form in the pancreas, often detected late. It can cause jaundice, weight loss, and abdominal pain, with risk factors including smoking and genetics.
New Investigator Award, Harcourt General, Chestnut Hill, MA (2000 – 2002)
Howard Temin Award, National Cancer Institute (2001-2006)
Kimmel Scholar Award, Sidney Kimmel Foundation, Philadelphia, PA (2002-2004)
Excellence in Teaching Award, UMMS Department of Medicine, Worcester, MA (2007)
Hoag Family Cancer Institute
Hoag's Colorectal Program offers advanced care for bowel disorders, from screening to recovery. Our expert surgeons are national leaders in minimally invasive and robotic-assisted procedures.
More about this programHoag Family Cancer Institute
Hoag leads cutting-edge clinical trials in esophageal cancer, using immunotherapy and personalized treatments to improve survival and quality of life.
More about this programHoag Family Cancer Institute
Hoag offers advanced diagnostics, innovative treatments, and clinical trials, delivered by a multidisciplinary team focused on personalized, compassionate care.
More about this program